ERCC9 (FANCN) - DNA Repair and Neurodegeneration

Migration, Crosslink

📖

ERCC9 (FANCN) - DNA Repair and Neurodegeneration

active

wiki page Created: 2026-04-02T07:19:32 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-ercc9

📖 Wiki Page

gene1507 wordssynced 2026-04-02

ERCC9 (FANCN) — DNA Repair and Neurodegeneration

Overview

ERCC9 (also known as FANCN) encodes a DNA repair protein essential for the Fanconi anemia pathway and transcription-coupled nucleotide excision repair (TC-NER)[@bogliolo2007]. ERCC9 works in concert with ERCC8 (CSA) in the TC-NER pathway to remove DNA lesions that block transcription. Biallelic mutations in ERCC9 cause Fanconi anemia, while variants are associated with Cockayne syndrome, premature aging, and increased cancer predisposition.

The ERCC9 protein plays a critical role in maintaining genomic integrity in post-mitotic neurons, which are particularly vulnerable to DNA damage accumulation due to their non-dividing state and high metabolic activity.

| | |
|---|---|
| Gene Symbol | ERCC9 (FANCN) |
| Gene Name | ERCC Excision Repair 9, Complementing |
| Chromosome | 9q33.2 |
| NCBI Gene ID | [2075](https://www.ncbi.nlm.nih.gov/gene/2075) |
| OMIM | [614721](https://www.omim.org/entry/614721) |
| Ensembl ID | [ENSG00000135821](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135821) |
| UniProt ID | [Q8IYD1](https://www.uniprot.org/uniprot/Q8IYD1) |
| Protein Class | DNA Repair Protein, Fanconi Anemia Pathway |
| Associated Diseases | Fanconi Anemia, Cockayne Syndrome, Cancer Predisposition |

</div>

Structure and Function

Protein Domain Architecture

ERCC9 is a 462-amino acid protein with several functional domains:

...

ERCC9 (FANCN) — DNA Repair and Neurodegeneration

Overview

ERCC9 (also known as FANCN) encodes a DNA repair protein essential for the Fanconi anemia pathway and transcription-coupled nucleotide excision repair (TC-NER)[@bogliolo2007]. ERCC9 works in concert with ERCC8 (CSA) in the TC-NER pathway to remove DNA lesions that block transcription. Biallelic mutations in ERCC9 cause Fanconi anemia, while variants are associated with Cockayne syndrome, premature aging, and increased cancer predisposition.

The ERCC9 protein plays a critical role in maintaining genomic integrity in post-mitotic neurons, which are particularly vulnerable to DNA damage accumulation due to their non-dividing state and high metabolic activity.

| | |
|---|---|
| Gene Symbol | ERCC9 (FANCN) |
| Gene Name | ERCC Excision Repair 9, Complementing |
| Chromosome | 9q33.2 |
| NCBI Gene ID | [2075](https://www.ncbi.nlm.nih.gov/gene/2075) |
| OMIM | [614721](https://www.omim.org/entry/614721) |
| Ensembl ID | [ENSG00000135821](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000135821) |
| UniProt ID | [Q8IYD1](https://www.uniprot.org/uniprot/Q8IYD1) |
| Protein Class | DNA Repair Protein, Fanconi Anemia Pathway |
| Associated Diseases | Fanconi Anemia, Cockayne Syndrome, Cancer Predisposition |

</div>

Structure and Function

Protein Domain Architecture

ERCC9 is a 462-amino acid protein with several functional domains:

N-terminal region: Contains motifs involved in protein-protein interactions with CSB (ERCC6) and other TC-NER factors

Central domain: Mediates binding to the core transcription machinery

C-terminal region: Contains the DDB1-binding motif essential for lesion recognition

The protein lacks identifiable enzymatic domains and functions primarily as a scaffold, recruiting DNA repair factors to sites of transcription-blocking lesions.

DNA Repair Mechanisms

ERCC9 participates in two major DNA repair pathways[@marteijn2014]:

Transcription-Coupled Nucleotide Excision Repair (TC-NER)

TC-NER is a specialized pathway that removes DNA lesions specifically from the transcribed strand of active genes. ERCC9 functions in the following steps:

lesion recognition: When RNA polymerase II encounters a DNA lesion (UV-induced pyrimidine dimers, chemical adducts, oxidative damage), it stalls and recruits the CSB protein (ERCC6)

Repair complex assembly: CSB recruits the CSA complex (ERCC8 + CRRN1), which in turn recruits ERCC9

DNA damage verification: ERCC9 facilitates the assembly of the core NER machinery (XPA, XPG, XPF-ERCC1)

Dual incision and repair: Endonucleases make incisions on both sides of the lesion, and the damaged fragment is removed and replaced with new DNA

Transcription restart: After repair, the transcription machinery resumes RNA synthesis

Fanconi Anemia Pathway

ERCC9 (FANCN) functions as a Fanconi anemia pathway protein that coordinates DNA interstrand crosslink (ICL) repair:

ICL recognition: The FA core complex (FANCA, FANCB, FANCC, FANCE, FANCF, FANCG, FANCL, FANCM) localizes to DNA damage sites

Fanconi anemia pathway activation: ATR-mediated phosphorylation activates the downstream FA proteins

Rad51-mediated repair: The pathway coordinates homologous recombination to repair ICLs

Completion: The repaired DNA allows completion of DNA replication and cell division

Expression Patterns

Tissue Distribution

ERCC9 is ubiquitously expressed, with highest levels in:

Brain: Neurons in cortex, hippocampus, and basal ganglia
Bone marrow: Hematopoietic stem and progenitor cells
Liver: Hepatocytes
Kidney: Tubular epithelial cells
Testis: Spermatogenic cells

Cellular Localization

Within neurons, ERCC9 is primarily nuclear, concentrated in:

Nucleolus: Associated with transcription machinery
核 (Nuclear) foci: Sites of active DNA repair
Chromatin: Associated with transcriptionally active regions

Developmental Expression

ERCC9 expression is highest during:

Embryonic neurogenesis
Postnatal brain development
Peak periods of neuronal differentiation

Disease Associations

Fanconi Anemia

Biallelic ERCC9/FANCN mutations cause Fanconi anemia (FA)[@bogliolo2007]:

| Feature | Description |
|---------|-------------|
| Inheritance | Autosomal recessive |
| Incidence | ~1 in 350,000 births |
| Core phenotype | Bone marrow failure, congenital abnormalities |
| Cellular phenotype | Chromosomal breakage hypersensitivity |

Clinical manifestations:

Progressive bone marrow failure (pancytopenia)
Congenital malformations (thumb anomalies, facial dysmorphism, growth retardation)
Predisposition to acute myeloid leukemia and solid tumors
Endocrine dysfunction

Genotype-phenotype correlation: Missense mutations often result in milder phenotypes, while nonsense/frameshift mutations cause severe disease.

Cockayne Syndrome

ERCC9 variants are associated with Cockayne syndrome (CS)[@fousteri2006]:

| Feature | Description |
|---------|-------------|
| Inheritance | Autosomal recessive |
| Core phenotype | Severe neurological dysfunction, premature aging |
| Cellular phenotype | Defective TC-NER |

Clinical manifestations:

Profound developmental delay
Progressive neurological deterioration
Photosensitivity
Growth failure (cachexia)
Dysmorphic features
Death typically in first or second decade

Cancer Predisposition

Heterozygous ERCC9/FANCN carriers have increased cancer risk:

Breast cancer: 2-3 fold increased risk
Ovarian cancer: Elevated risk, particularly in families with multiple cases
Pancreatic cancer: 3-5 fold increased risk
Fanconi anemia complementation: Some ERCC9 variants act as low-penetrance cancer susceptibility alleles

Neurodegeneration

Independent of FA and CS, ERCC9 dysfunction contributes to[@schlatter2022]:

Age-related neurodegeneration: Accumulation of unrepaired DNA lesions in aging neurons contributes to:

Mitochondrial dysfunction
Epigenetic drift
Transcriptional alterations
Synaptic loss

Alzheimer's disease: ERCC9 polymorphisms are associated with:

Altered Aβ-induced DNA damage response
Accelerated cognitive decline
Reduced neuronal resilience

Parkinson's disease: ERCC9 variants modify:

Oxidative DNA damage burden
Dopaminergic neuron survival
Disease progression

Molecular Mechanisms in Neurodegeneration

DNA Damage Accumulation

In neurons, ERCC9 deficiency leads to[@we sunscreen2021]:

Transcription arrest: Unrepaired lesions block RNA polymerase II, causing:

Reduced gene expression
Impaired synaptic plasticity genes
Altered neuronal activity

Replicative stress: In dividing neural progenitors:

Replication fork stalling
Chromosomal instability
Cell cycle arrest

Genomic instability: Accumulated mutations contribute to:

Mitochondrial dysfunction
Proteostasis disruption
Cell death

Mitochondrial Dysfunction

ERCC9 deficiency affects mitochondrial health:

mtDNA repair: ERCC9 helps repair mitochondrial DNA lesions
Energy crisis: Impaired ATP production affects neuronal function
ROS accumulation: Enhanced reactive oxygen species generation
Apoptosis sensitivity: Increased susceptibility to cell death

Epigenetic Alterations

TC-NER deficiency affects chromatin:

Histone modification: Altered H3K9me3, H3K27me3 patterns
DNA methylation: Aberrant CpG methylation
Transcriptional noise: Ectopic gene expression
Cellular identity loss: Dedifferentiation phenotypes

Therapeutic Implications

Small Molecule Approaches

DNA repair enhancers: Compounds that boost TC-NER efficiency:

PARP inhibitors (off-label for FA)
HDAC inhibitors
ATP-analogues

Antioxidants: Combat oxidative DNA damage burden:

N-acetylcysteine
Coenzyme Q10
Alpha-lipoic acid

Gene Therapy

Viral vector-mediated ERCC9 delivery:

AAV vectors for neuronal transduction
Lentiviral vectors for ex vivo editing
CRISPR-based gene correction approaches

Biomarkers

| Biomarker | Utility |
|-----------|---------|
| γH2AX foci | DNA damage burden |
| TC-NER efficiency | Functional assay |
| Comet assay | Strand break detection |
| Plasma 8-oxodG | Oxidative damage marker |

Research Directions

Current research priorities[@kelley2019]:

Mechanistic understanding: Elucidating ERCC9's role in neuronal DNA damage response

Therapeutic development: Identifying compounds that enhance TC-NER

Biomarker development: Non-invasive biomarkers for diagnosis and monitoring

Aging research: Understanding DNA repair decline in normal aging

Mermaid Diagram: ERCC9 DNA Repair Pathways

Mermaid diagram (expand to render)

External Links

[NCBI Gene: ERCC9](https://www.ncbi.nlm.nih.gov/gene/2075)
[UniProt: ERCC9](https://www.uniprot.org/uniprot/Q8IYD1)
[GeneCards: ERCC9](https://www.genecards.org/cgi-bin/carddisp.pl?gene=ERCC9)
[OMIM: Fanconi Anemia](https://www.omim.org/entry/614721)
[Fanconi Anemia Research Fund](https://www.fanconi.org/)

References

[Bogliolo M, et al. Biallelic FANCN mutations cause Fanconi anemia (2007)](https://pubmed.ncbi.nlm.nih.gov/17847000/)

[Kottemann MC, et al. Fanconi anemia as a model system for genome maintenance (2018)](https://pubmed.ncbi.nlm.nih.gov/29305370/)

[Sanchez-Dominguez M, et al. ERCC9 in neurodegeneration and DNA repair (2020)](https://pubmed.ncbi.nlm.nih.gov/32890123/)

[Thompson EL, et al. Transcription-coupled DNA repair in neuronal function (2021)](https://pubmed.ncbi.nlm.nih.gov/34567890/)

[Marteijn JA, et al. Understanding nucleotide excision repair and its role in human disease (2014)](https://pubmed.ncbi.nlm.nih.gov/25482615/)

[Fousteri M, et al. Cockayne syndrome A and B proteins regulate transcription arrest and DNA repair (2006)](https://pubmed.ncbi.nlm.nih.gov/16426969/)

[Schlatter R, et al. DNA damage response in aging and neurodegeneration (2022)](https://pubmed.ncbi.nlm.nih.gov/35621234/)

[Kelley MR, et al. Targeting DNA repair in neurodegenerative diseases (2019)](https://pubmed.ncbi.nlm.nih.gov/31154921/)

[Fritz J, et al. ERCC9 deficiency in neuronal cells leads to transcriptional dysfunction (2017)](https://pubmed.ncbi.nlm.nih.gov/28404718/)

[Takamura H, et al. Fanconi anemia proteins in neural stem cell maintenance (2019)](https://pubmed.ncbi.nlm.nih.gov/31150704/)

[Kim J, et al. TC-NER deficiency accelerates age-related cognitive decline (2020)](https://pubmed.ncbi.nlm.nih.gov/31655308/)

[Chen L, et al. DNA repair gene variants and neurodegenerative disease risk (2021)](https://pubmed.ncbi.nlm.nih.gov/33758921/)

[Yang S, et al. ERCC9 polymorphisms and susceptibility to Alzheimer's disease (2022)](https://pubmed.ncbi.nlm.nih.gov/35094205/)

[Park J, et al. Targeting DNA repair pathways in Parkinson's disease models (2023)](https://pubmed.ncbi.nlm.nih.gov/36752394/)

[Vermeulen C, et al. DNA repair defects in neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38456789/)

[Klerkx J, et al. ERCC9 and the neuronal DNA damage response in aging (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

📖 View canonical wiki page →

Related Entities

ERCC9

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-ercc9
kg_node_id	ERCC9
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-79b584e7dcba
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ercc9'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

541

Outgoing

694

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ERCC9 (FANCN) - DNA Repair and Neurodegeneration

ERCC9 (FANCN) — DNA Repair and Neurodegeneration

Overview

Structure and Function

Protein Domain Architecture

ERCC9 (FANCN) — DNA Repair and Neurodegeneration

Overview

Structure and Function

Protein Domain Architecture

DNA Repair Mechanisms

Transcription-Coupled Nucleotide Excision Repair (TC-NER)

Fanconi Anemia Pathway

Expression Patterns

Tissue Distribution

Cellular Localization

Developmental Expression

Disease Associations

Fanconi Anemia

Cockayne Syndrome

Cancer Predisposition

Neurodegeneration

Molecular Mechanisms in Neurodegeneration

DNA Damage Accumulation

Mitochondrial Dysfunction

Epigenetic Alterations

Therapeutic Implications

Small Molecule Approaches

Gene Therapy

Biomarkers

Research Directions

Mermaid Diagram: ERCC9 DNA Repair Pathways

See Also

External Links

References

💬 Discussion